Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-000717-20Phase 3Completed
Phase 3, randomised, double-blind trial in Focal Onset Epilepsy and epilepsy comparing Lacosamide adjunctive therapy with Placebo adjunctive therapy (2 arms). Primary endpoint: Responder rate based on electrographic partial-onset seizures. Started Mar 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-000717-20.